Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Public ClinicalTrials.gov record NCT00003405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Treatment Protocol for Patients With Standard Risk Acute Myelogenous Leukemia and Its Variants: Induction Using High-Dose Cytarabine, Mitoxantrone and Ethyol; Consolidation With Cytarabine and Idarubicin and Maintenance With 13 Cis Retinoic Acid and Alpha Interferon
Study identification
- NCT ID
- NCT00003405
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Rush University Medical Center
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- amifostine trihydrate Drug
- bromodeoxyuridine Drug
- cytarabine Drug
- idarubicin Drug
- idoxuridine Drug
- isotretinoin Drug
- mitoxantrone hydrochloride Drug
- recombinant interferon alfa Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 0 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 1998
- Primary completion
- Mar 31, 1999
- Completion
- Mar 31, 1999
- Last update posted
- Oct 13, 2021
1998 – 1999
United States locations
- U.S. sites
- 4
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cook County Hospital | Chicago | Illinois | 60612-9985 | — |
| Rush Cancer Institute | Chicago | Illinois | 60612 | — |
| Angelo P. Creticos, M.D. Cancer Center | Chicago | Illinois | 60657 | — |
| Rush-Riverside Cancer Center | Kankakee | Illinois | 60901 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00003405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2021 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00003405 live on ClinicalTrials.gov.